According to our (Global Info Research) latest study, the global Molecular Diagnostic Analyzer market size was valued at US$ 7048 million in 2025 and is forecast to a readjusted size of US$ 12483 million by 2032 with a CAGR of 8.7% during review period.
In 2025, global Molecular Diagnostic Analyzer production reached approximately 180,000 units, with an average global market price of around USD 38,000 per unit.
The gross profit margin of major companies in the industry is between 45%–65%.
In 2025, the global production capacity of Molecular Diagnostic Analyzer was approximately 240,000 units.
Molecular Diagnostic Analyzer is an in vitro diagnostic instrument designed to detect and analyze nucleic acids, genetic markers, and molecular biomarkers from clinical specimens. The system integrates sample preparation, nucleic acid amplification, fluorescence detection, and data analysis to provide rapid, accurate, and highly sensitive diagnostic results. It is widely used for infectious disease diagnosis, oncology testing, genetic disease screening, transplant monitoring, and precision medicine. The product scope includes PCR analyzers, isothermal amplification systems, multiplex molecular diagnostic platforms, and fully automated molecular diagnostic analyzers, while excluding standalone reagent kits and laboratory automation equipment.
The industry chain includes upstream suppliers of optical components, precision mechanical parts, microfluidic modules, thermal control systems, electronic components, and diagnostic consumables. Midstream covers instrument design, hardware manufacturing, software development, system integration, calibration, and quality testing. Downstream applications include hospitals, clinical laboratories, public health institutions, blood centers, research laboratories, and third-party diagnostic service providers.
This report is a detailed and comprehensive analysis for global Molecular Diagnostic Analyzer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Molecular Diagnostic Analyzer market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Molecular Diagnostic Analyzer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Molecular Diagnostic Analyzer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Molecular Diagnostic Analyzer market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Diagnostic Analyzer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Diagnostic Analyzer market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation (Cepheid), Thermo Fisher Scientific Inc., bioMérieux S.A., QIAGEN N.V., Becton, Dickinson and Company, Hologic, Inc., Seegene Inc., Sysmex Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Molecular Diagnostic Analyzer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
PCR Molecular Diagnostic Analyzer
Isothermal Amplification Molecular Diagnostic Analyzer
Next-generation Sequencing Molecular Diagnostic Analyzer
Market segment by Automation Level
Fully Automated Molecular Diagnostic Analyzer
Semi-automated Molecular Diagnostic Analyzer
Portable Molecular Diagnostic Analyzer
Market segment by Sample Throughput
Low Throughput Analyzer (≤24 Tests/Run)
Medium Throughput Analyzer (25–96 Tests/Run)
High Throughput Analyzer (>96 Tests/Run)
Market segment by Application
Infectious Disease Testing
Oncology Testing
Genetic Disease Testing
Other
Major players covered
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Danaher Corporation (Cepheid)
Thermo Fisher Scientific Inc.
bioMérieux S.A.
QIAGEN N.V.
Becton, Dickinson and Company
Hologic, Inc.
Seegene Inc.
Sysmex Corporation
Bio-Rad Laboratories, Inc.
Biocartis Group NV
Da'an Gene Co., Ltd.
Sansure Biotech Inc.
Shanghai ZJ Bio-Tech Co., Ltd.
Jiangsu Bioperfectus Technologies Co., Ltd.
Shanghai Kehua Bio-Engineering Co., Ltd.
Guangzhou Wondfo Biotech Co., Ltd.
Maccura Biotechnology Co., Ltd.
CapitalBio Technology Corporation
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Molecular Diagnostic Analyzer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Molecular Diagnostic Analyzer, with price, sales quantity, revenue, and global market share of Molecular Diagnostic Analyzer from 2021 to 2026.
Chapter 3, the Molecular Diagnostic Analyzer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Molecular Diagnostic Analyzer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Molecular Diagnostic Analyzer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Molecular Diagnostic Analyzer.
Chapter 14 and 15, to describe Molecular Diagnostic Analyzer sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Molecular Diagnostic Analyzer. Industry analysis & Market Report on Molecular Diagnostic Analyzer is a syndicated market report, published as Global Molecular Diagnostic Analyzer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Molecular Diagnostic Analyzer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.